Effect of rifampin on the pharmacokinetics of Axitinib (AG-013736) in Japanese and Caucasian healthy volunteers

PURPOSE: Axitinib, a potent and selective inhibitor of vascular endothelial growth factor receptors 1, 2, 3, is metabolized by cytochrome P450 3A4 and glucuronidation. This study evaluated the effect of rifampin, a potent inducer of drug-metabolizing enzymes, on axitinib plasma pharmacokinetics. Equ...

Descripción completa

Detalles Bibliográficos
Autores principales: Pithavala, Y. K., Tortorici, M., Toh, M., Garrett, M., Hee, B., Kuruganti, U., Ni, G., Klamerus, K. J.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797436/
https://www.ncbi.nlm.nih.gov/pubmed/19603168
http://dx.doi.org/10.1007/s00280-009-1065-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797436/
https://www.ncbi.nlm.nih.gov/pubmed/19603168
http://dx.doi.org/10.1007/s00280-009-1065-y

Ejemplares similares